Mold Antigens Liquid
NDC Package 44911-0702-1
Package Information
Mold Antigens (arsenicum album, histaminum hydrochloricum, natrum sulphuricum, phosphorus, pulsatilla (pratensis), sepia, thuja occidentalis, alternaria tenuis nees, aspergillus niger, candida albicans, candida parapsilosis, torula cerevisiae, mucor racemosus, rhizopus nigricans) liquids is • Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional.• Consult a physician for use in children under 12 years of age. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0702.
Identification & Billing
Clinical Specifications
- ALTERNARIA ALTERNATA 30 [hp_X]/mL
- ARSENIC TRIOXIDE 12 [hp_X]/mL
- ASPERGILLUS NIGER VAR. NIGER 30 [hp_X]/mL
- CANDIDA ALBICANS 30 [hp_X]/mL
- CANDIDA PARAPSILOSIS 30 [hp_X]/mL
- HISTAMINE DIHYDROCHLORIDE 12 [hp_X]/mL
- MUCOR RACEMOSUS 30 [hp_X]/mL
- PHOSPHORUS 12 [hp_X]/mL
- PULSATILLA PRATENSIS WHOLE 12 [hp_X]/mL
- RHIZOPUS STOLONIFER 30 [hp_C]/mL
- SACCHAROMYCES CEREVISIAE 30 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 12 [hp_X]/mL
- SODIUM SULFATE 12 [hp_X]/mL
- THUJA OCCIDENTALIS LEAFY TWIG 12 [hp_X]/mL
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Fungal Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Fungal Allergenic Extract - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0702 - Mold Antigens
- 44911-0702-1 - 30 mL in 1 BOTTLE, DROPPER
- 44911-0702 - Mold Antigens
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0702-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Mold Antigens, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains alternaria alternata; arsenic trioxide; aspergillus niger var. niger; candida albicans; candida parapsilosis; histamine dihydrochloride; mucor racemosus; phosphorus; pulsatilla pratensis whole; rhizopus stolonifer; saccharomyces cerevisiae; sepia officinalis juice; sodium sulfate; thuja occidentalis leafy twig as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on December 22, 2023. The current certification is valid through December 31, 2026.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911070201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.